Clinical Trial Update: The Effect of Intranasal Insulin on Neurocognitive Function in Euthymic Patients With Bipolar Disorder [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the effect of intranasal insulin on neurocognitive function in euthymic patients with bipolar disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Intranasal insulin (insulin)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Bipolar Disorder | Phase 3 | Status: COMPLETED